268 related articles for article (PubMed ID: 34404534)
1. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
Karantanos T; DeZern AE
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
[TBL] [Abstract][Full Text] [Related]
2. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
3. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
Schaefer EJ; Lindsley RC
Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
[TBL] [Abstract][Full Text] [Related]
4. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of clonal hematopoiesis and disease boundaries in bone marrow failure diseases].
Suzuki T
Rinsho Ketsueki; 2023; 64(6):474-481. PubMed ID: 37407470
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract][Full Text] [Related]
7. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
8. Marrow failure.
Bagby GC; Lipton JM; Sloand EM; Schiffer CA
Hematology Am Soc Hematol Educ Program; 2004; ():318-36. PubMed ID: 15561690
[TBL] [Abstract][Full Text] [Related]
9. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
Zeidan AM; Battiwalla M; Berlyne D; Winkler T
Leuk Res; 2017 Feb; 53():8-12. PubMed ID: 27923195
[TBL] [Abstract][Full Text] [Related]
10. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
11. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
12. [Ferrokinetics and bone marrow scanning in patients with myelodysplastic syndrome, hypoplastic myelodysplastic syndrome and aplastic anemia].
Ohno Y; Takahashi Y; Yoshida Y
Rinsho Ketsueki; 1993 Mar; 34(3):260-4. PubMed ID: 8479076
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
16. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
17. Hypoplastic form of myelodysplastic neoplasm.
Votavová H; Lenertová Z; Votava T; Beličková M
Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of childhood myelodysplastic syndrome].
Hasegawa D
Rinsho Ketsueki; 2021; 62(4):229-238. PubMed ID: 33967145
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
Frietsch JJ; Dornaus S; Neumann T; Scholl S; Schmidt V; Kunert C; Sayer HG; Hochhaus A; La Rosée P
Eur J Haematol; 2014 Sep; 93(3):247-59. PubMed ID: 24635656
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium.
Nakano TA; Lau BW; Dickerson KE; Wlodarski M; Pollard J; Shimamura A; Hofmann I; Sasa G; Elghetany T; Cada M; Dror Y; Ding H; Allen SW; Hanna R; Campbell K; Olson TS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28652. PubMed ID: 32779892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]